Today is an especially ominous anniversary on Wall Street
, October has had more than its fair share of stock market horror stories, and Halloween is almost here. Yet fat cats continue to win out over ‘fraidy cats. With Spain, land of the matador, officially out of recession
, the bull is proving terribly tough to kill. Kill Bill? Not if you are birthday boy Mr. Gates, 58 today, who just bet big on Iberia himself
and saw his Microsoft
(NASDAQ:MSFT) surge 5.96% to top all Dow
(INDEXDJX:.DJI) issues on Friday. Over at fellow blue chip Procter & Gamble
(NYSE:PG), CEO A.G. Lafley is skipping conference calls
, a Teutonic shift likely inspired by the telephone travails of Ms. Merkel
. Telecom titan AT&T Inc.
(NYSE:T), whose net income rose 5% to $3.91 billion, needn’t have any hang-ups, however. Especially after Kanye West proposed to Kim Kardashian in typically understated fashion on the jumbotron at San Francisco’s AT&T Park. (Here’s the happy couple
This morning in economic data, September pending home sales are due at 10:00 a.m. Eastern. On the corporate front, just under half of the S&P 500 Index
(INDEXSP:.INX) have now released quarterly results. Today’s announcements are expected to include América Móvil
(NASDAQ:AAPL), Biogen Idec
(NYSE:HLF), Linn Energy
(NASDAQ:LINE), Loews Corporation
(NYSE:MRK), Riverbed Technology
(NASDAQ:RVBD), Seagate Technology
(NYSE:STX), and TNT Express
(NASDAQ:FATE): The biotech, an insider favorite
, is begun with bullish Outperforms by BMO Capital, Cowen, and Wedbush ($14 price objective.) The company’s principal product, ProHema for hematopoietic stem cell transplantation (HSCT), shows promise.
(NYSE:GIMO): GIMO gets initiated with an Outperform at William Blair.
(NASDAQ:AWAY): Cowen covers the stock at Outperform.
International Game Technology
(NYSE:IGT): Citigroup starts the maker of casino games at a Buy.
(NYSE:RMAX): Calling the company a way to play an ongoing US housing recovery, RBC Capital resumes Outperform-rated research. Its price objective is $33.
(NYSE:RKUS): Northland Capital has a new Market Perform rating, and $18 target price, on the stock.
(NASDAQ:SCTY): The alternative energy name is assigned an Outperform at Credit Suisse.
(See also: Stock Upgrades: AstraZeneca Has It Covered From A to Z
and Stock Downgrades: Crocs Takes a Walk on the Wild Side
No positions in stocks mentioned.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.
Copyright 2011 Minyanville Media, Inc. All Rights Reserved.